Nephrotic Syndrome Associated with Thymoma

by Sheng-Yen Hsiao, Kwang-Yu Chang, Jang-Yang Chang, Wu-Chou Su
Published 2014-12-01

The Emergent Landscape of Detecting EGFR Mutations Using Circulating Tumor DNA in Lung Cancer

by Wei-Lun Huang, Fang Wei, David T. Wong, Chien-Chung Lin, Wu-Chou Su
Published 2015-01-01

Nanomedicine-Based Strategies Assisting Photodynamic Therapy for Hypoxic Tumors: State-of-the-Art Approaches and Emerging Trends

by Chun-Yan Shih, Pei-Ting Wang, Wu-Chou Su, Hsisheng Teng, Wei-Lun Huang
Published 2021-02-01

First‐line treatment with irreversible tyrosine kinase inhibitors associated with longer OS in EGFR mutation‐positive non‐small cell lung cancer

by Po‐Lan Su, Chian‐Wei Chen, Yi‐Lin Wu, Chien‐Chung Lin, Wu‐Chou Su
Published 2021-02-01

Primary Bone Marrow Large B-cell Lymphoma Presenting with Hemophagocytic Lymphohistiocytosis

by Sin-Syue Li, Ya-Ping Chen, Kung-Chao Chang, Wu-Chou Su, Tsai-Yun Chen
Published 2014-09-01

Comparative effectiveness and cost-effectiveness of three first-line EGFR-tyrosine kinase inhibitors: Analysis of real-world data in a tertiary hospital in Taiwan.

by Szu-Chun Yang, Wu-Wei Lai, Jason C Hsu, Wu-Chou Su, Jung-Der Wang
Published 2020-01-01

Iron Release Profile of Silica-Modified Zero-Valent Iron NPs and Their Implication in Cancer Therapy

by Li-Xing Yang, Ya-Na Wu, Pei-Wen Wang, Wu-Chou Su, Dar-Bin Shieh
Published 2019-09-01

Development of the CK‐MB‐1 trastuzumab‐resistant HER2‐positive breast cancer cell line and xenograft animal models

by Wei‐Pang Chung, Wei‐Lun Huang, Wei‐An Liao, Wan‐Ling Huang, You‐Yu Liu, Wu‐Chou Su
Published 2021-04-01

Immune Checkpoint Inhibitor-Induced Myasthenia Gravis

by Yi-Te Huang, Ya-Ping Chen, Wen-Chih Lin, Wu-Chou Su, Yuan-Ting Sun, Yuan-Ting Sun
Published 2020-07-01

The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis.

by Wei-Yuan Chang, Yi-Lin Wu, Po-Lan Su, Szu-Chun Yang, Chien-Chung Lin, Wu-Chou Su
Published 2018-01-01

Upregulation of tissue factor by activated Stat3 contributes to malignant pleural effusion generation via enhancing tumor metastasis and vascular permeability in lung adenocarcinom...

by Hsuan-Heng Yeh, Wen-Tsan Chang, Kuang-Chu Lu, Wu-Wei Lai, Hsiao-Sheng Liu, Wu-Chou Su
Published 2013-01-01

Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors

by Hui-Jen Tsai, Her-Shyong Shiah, Jang-Yang Chang, Wu-Chou Su, Nai-Jung Chiang, Li-Tzong Chen
Published 2021-03-01

Dynamic changes in quality of life after three first-line therapies for EGFR mutation-positive advanced non-small-cell lung cancer

by Szu-Chun Yang, Chien-Chung Lin, Wu-Wei Lai, Sheng-Mao Chang, Jing-Shiang Hwang, Wu-Chou Su, Jung-Der Wang
Published 2018-02-01

Psychometric evaluation of the WHOQOL-BREF, Taiwan version, across five kinds of Taiwanese cancer survivors: Rasch analysis and confirmatory factor analysis

by Chung-Ying Lin, Jing-Shiang Hwang, Wen-Chung Wang, Wu-Wei Lai, Wu-Chou Su, Tzu-Yi Wu, Grace Yao, Jung-Der Wang
Published 2019-01-01

Oncogenic Ras-Induced Morphologic Change Is through MEK/ERK Signaling Pathway to Downregulate Stat3 at a Posttranslational Level in NIH3T3 Cells

by Hsuan-Heng Yeh, Chin-Han Wu, Raghavaraju Giri, Ken Kato, Kimitoshi Kohno, Hiroto Izumi, Cheng-Yang Chou, Wu-Chou Su, Hsiao-Sheng Liu
Published 2008-01-01

Durable Response to Combined Dabrafenib and Trametinib in a Patient With BRAF K601E Mutation-Positive Lung Adenocarcinoma: A Case Report

by Po-Lan Su, MD, Chien-Yu Lin, MD, Yi-Lin Chen, MS, Wan-Li Chen, MS, Chien-Chung Lin, MD, PhD, Wu-Chou Su, MD
Published 2021-08-01

Extracellular Vesicle miR-200c Enhances Gefitinib Sensitivity in Heterogeneous EGFR-Mutant NSCLC

by Chien-Chung Lin, Chin-You Wu, Joseph T. Tseng, Chun-Hua Hung, Shang-Yin Wu, Yu-Ting Huang, Wei-Yuan Chang, Po-Lan Su, Wu-Chou Su
Published 2021-02-01

Preventing and treating brain metastases with three first-line EGFR-tyrosine kinase inhibitors in patients with EGFR mutation-positive advanced non-small cell lung cancer

by Po-Lan Su, Yi-Lin Wu, Wei-Yuan Chang, Chung-Liang Ho, Yau-Lin Tseng, Wu-Wei Lai, Wu-Chou Su, Chien-Chung Lin, Szu-Chun Yang
Published 2018-09-01

EGFR-TKI plus bevacizumab versus EGFR-TKI monotherapy for patients with EGFR mutation-positive advanced non-small cell lung cancer-A propensity score matching analysis

by Jeng-Shiuan Tsai, Po-Lan Su, Szu-Chun Yang, Chao-Chun Chang, Chia-Ying Lin, Yi-Ting Yen, Yau-Lin Tseng, Wu-Wei Lai, Chien-Chung Lin, Wu-Chou Su
Published 2021-09-01

Cost effectiveness of cancer treatment in Taiwan

by Mei-Chuan Hung, Wu-Wei Lai, Helen H.W. Chen, Jenq-Chang Lee, Yih-Jyh Lin, Jenn-Ren Hsiao, Ya-Min Cheng, Yan-Shen Shan, Wu-Chou Su, Jung-Der Wang
Published 2016-08-01